BSRT Events 2021

Sustainable Investor Relations

ESG integration is the new normal — What investors expect now Disclosure strategy and internal collaboration across functional areas Best practice within and beyond biopharma

Future-Proof Biopharma

Challenge of target-setting in the social dimension Science-based targets beyond Carbon The next big thing: Taxes? Biodiversity? Social taxonomy? 

Biopharma CEO Investor Forum

The Biopharma Sustainability Roundtable (BSRT) and CECP’s CEO Investor Forum invite you to join nine leading leading biopharma CEOs for the first-ever sector-specific Biopharma CEO Investor Forum, June 7-8, 2021. CEOs from Catalent, GlaxoSmithKline, Incyte, Merck & Co., Moderna, Pfizer, Sanofi, Takeda, and UCB will share their Long-Term Plans for sustainable value creation with leading

Regulatory and ESG Policy Outlook for Biopharma

Roundtable Forum with Eco:Fact Update on global hard and soft regulatory changes affecting biopharma Focus on EU: Green Deal, Circular Economy, Sustainable Finance, Non-Financial Reporting Directive Speaker: Olivier Jaeggi, Managing Director, ECO:FACT Video presentation is available to Roundtable members upon request. Please contact us if you are interested.

Business Leadership and Governance in Biopharma

Roundtable Forum with Lise Kingo Biopharma sustainability oversight and governance priorities Speaker: Lise Kingo, Independent Director, Sanofi; former Executive Director, UN Global Compact Video presentation is available to Roundtable members upon request. Please contact us if you are interested.

Is Biopharma Future-Proof? ESG and Long-Term Planning

Connecting Biopharma Sustainability and Long-Term Planning — A collaboration with CECP’s CEO Investor Forum. Initial release of our Executive Report and Practitioner’s Guide for integrating sustainability and long-term planning for biopharma companies.